[New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].
Sureda
A
A
Servicio de Hematologia, Hospital Ramón y Cajal, Madrid, España.
García Frade
L J
LJ
Navarro
J L
JL
D004341:Drug Evaluation; D005342:Fibrinolysis / Q000187:drug effects; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000302:isolation & purification / Q000627:therapeutic use*; D006801:Humans; D011183:Postoperative Complications / Q000517:prevention & control; D006435:Renal Dialysis; D013923:Thromboembolism / Q000188:drug therapy / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000188:drug therapy
D006495:Heparin, Low-Molecular-Weight
Nuevas opciones en la prevención y tratamiento de la enfermedad tromboembólica: las heparinas de bajo peso molecular.